CLINICAL_TRIALS
trial_result
· 2020-07-01
Clinical Trial Update: Metformin for the Prevention of Episodic Migraine (MPEM) [Phase 3]
Summary
A Phase 3 trial investigating metformin for the prevention of episodic migraine has completed and posted results in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2020-07-01